An Exploration of the Future of Pharmaceutical Value Assessments in the U.S.
Jeffrey J. Lemay
Advertisement
Articles by Jeffrey J. Lemay
Advertisement
Latest Updated Articles
Who is Driving the HTA Bus? And Where is it Headed?Published: October 9th 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
2
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
3
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
4
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
5
